Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-059890

Chief Dev. & Ops. Officer bought 1,278 shares at an average $15.85 ($20,255)

From the SEC's structured data for this filing

Trades in this filing

Shemesh Shay · Chief Dev. & Ops. Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-12 Purchase : show line 1 in the form +36 $14.58 $525 1,239,651 D
2022-05-12 Purchase : show line 2 in the form +1,184 $15.85 $18,766 1,240,835 D
2022-05-12 Purchase : show line 3 in the form +58 $16.61 $963 1,240,893 D
Open-market purchases · 1,278 sh · avg $15.85 · $20,255
Loading xslF345X03/tm2215423-5_4seq1.xml…